Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
SIBP-03 by Shanghai Institute of Biological Products for Recurrent Head And Neck Squamous Cell Carcinoma: Likelihood of Approval
SIBP-03 is under clinical development by Shanghai Institute of Biological Products and currently in Phase I for Recurrent Head And...